For Admin
A Leading Company in Nasal Drug Delivery
SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.
3D Nasal Cast Model
Nov 26, 2024
SNBL’s Subsidiary, Satsuma Pharmaceuticals Receives FDA Acceptance of NDA Resubmission of STS101 for the Acute Treatment of Migraine With or Without Aura
Oct 31, 2024
SNBL’s Subsidiary Satsuma Pharmaceuticals Resubmits New Drug Application for STS101 for Acute Treatment of Migraine With or Without Aura
Jan 18, 2024
FDA Issues Complete Response Letter for Satsuma’s STS101
2024|2023|2022|2021|2020|2019|2018|2016|2015|2014|2013|2012〜